Click to copy

Press release content from Business Wire. The AP news staff was not involved in its creation.

Click to copy

Female Fertility Rapid Tests - Global Medical Devices Pipeline Assessment Report, 2019 - ResearchAndMarkets.com

November 19, 2019 GMT

DUBLIN--(BUSINESS WIRE)--Nov 19, 2019--

The “Female Fertility Rapid Tests - Medical Devices Pipeline Assessment, 2019” report has been added to ResearchAndMarkets.com’s offering.

This report provides an overview of Female Fertility Rapid Tests currently in pipeline stage. The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development.

The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Female Fertility Rapid Tests pipeline products.

Scope

Reasons to Buy

Key Topics Covered

1 Table of Contents

2 Introduction

2.1 Female Fertility Rapid Tests Overview

3 Products under Development

3.1 Female Fertility Rapid Tests - Pipeline Products by Stage of Development

3.2 Female Fertility Rapid Tests - Pipeline Products by Segment

3.3 Female Fertility Rapid Tests - Pipeline Products by Territory

3.4 Female Fertility Rapid Tests - Pipeline Products by Regulatory Path

3.5 Female Fertility Rapid Tests - Pipeline Products by Estimated Approval Date

4 Female Fertility Rapid Tests - Pipeline Products under Development by Companies

4.1 Female Fertility Rapid Tests Companies - Pipeline Products by Stage of Development

4.2 Female Fertility Rapid Tests - Pipeline Products by Stage of Development

5 Female Fertility Rapid Tests Companies and Product Overview

5.1 BBB Technologies Inc Company Overview

5.2 Bio-AMD Inc.

5.3 ET Healthcare Inc.

5.4 MFB Fertility Inc.

5.5 NG Biotech

5.6 OPKO Health Inc.

5.7 Pop Test LLC

5.8 PragmaDX Inc.

5.9 Quidel Corp.

6 Female Fertility Rapid Tests - Recent Developments

6.1 Aug 08, 2019: Quidel reports second quarter 2019 Financial Results

6.2 May 28, 2019: True Diagnostics receives FDA 510(k) clearance to market VeriClear Digital Test Device for early result pregnancy

6.3 May 14, 2019: Sekisui Diagnostics invests $1.9 million in Microbial Biopharma CDMO business

6.4 May 08, 2019: Quidel reports first quarter 2019 financial results

6.5 Apr 01, 2019: Mologic expands US and UK operations

6.6 Feb 27, 2019: Sekisui Diagnostics expanding again and adding more jobs

6.7 Feb 13, 2019: Quidel Reports Fourth Quarter and Full Year 2018 Financial Results

6.8 Jan 07, 2019: Quidel Announces Preliminary Revenue for Fourth Quarter 2018

6.9 Nov 06, 2018: Quidel reports third quarter 2018 financial results

List of Tables

Table 1: Female Fertility Rapid Tests - Pipeline Products by Stage of Development

Table 2: Female Fertility Rapid Tests - Pipeline Products by Segment

Table 3: Female Fertility Rapid Tests - Pipeline Products by Territory

Table 4: Female Fertility Rapid Tests - Pipeline Products by Regulatory Path

Table 5: Female Fertility Rapid Tests - Pipeline Products by Estimated Approval Date

Table 6: Female Fertility Rapid Tests Companies - Pipeline Products by Stage of Development

Table 7: Female Fertility Rapid Tests - Pipeline Products by Stage of Development

Table 8: BBB Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview

Table 19: Bio-AMD Inc Pipeline Products & Ongoing Clinical Trials Overview

Table 24: ET Healthcare Inc Pipeline Products & Ongoing Clinical Trials Overview

Table 35: MFB Fertility Inc Pipeline Products & Ongoing Clinical Trials Overview

Table 38: NG Biotech Pipeline Products & Ongoing Clinical Trials Overview

Table 47: OPKO Health Inc Pipeline Products & Ongoing Clinical Trials Overview

Table 50: Pop Test LLC Pipeline Products & Ongoing Clinical Trials Overview

Table 53: PragmaDX Inc Pipeline Products & Ongoing Clinical Trials Overview

Table 56: Quidel Corp Pipeline Products & Ongoing Clinical Trials Overview

Table 59: Glossary

List of Figures

Figure 1: Female Fertility Rapid Tests - Pipeline Products by Stage of Development

Figure 2: Female Fertility Rapid Tests - Pipeline Products by Segment

Figure 3: Female Fertility Rapid Tests - Pipeline Products by Territory

Figure 4: Female Fertility Rapid Tests - Pipeline Products by Regulatory Path

Figure 5: Female Fertility Rapid Tests - Pipeline Products by Estimated Approval Date

For more information about this report visit https://www.researchandmarkets.com/r/sx5ha3

View source version on businesswire.com:https://www.businesswire.com/news/home/20191119005960/en/

CONTACT: ResearchAndMarkets.com

Laura Wood, Senior Press Manager

press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

KEYWORD:

INDUSTRY KEYWORD: HEALTH WOMEN CONSUMER MEDICAL DEVICES

SOURCE: Research and Markets

PUB: 11/19/2019 01:46 PM/DISC: 11/19/2019 01:46 PM

http://www.businesswire.com/news/home/20191119005960/en